These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21375408)

  • 1. A comparison of seven methods to analyze heparin in biomaterials: quantification, location, and anticoagulant activity.
    Lammers G; van de Westerlo EM; Versteeg EM; van Kuppevelt TH; Daamen WF
    Tissue Eng Part C Methods; 2011 Jun; 17(6):669-76. PubMed ID: 21375408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-like macromolecules for the modification of anticoagulant biomaterials.
    Ran F; Nie S; Li J; Su B; Sun S; Zhao C
    Macromol Biosci; 2012 Jan; 12(1):116-25. PubMed ID: 21976247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V; Summerhayes R; Gan A; Than J; Chan A; Cochrane A; Bennett M; Horton S; Shann F; Lane G; Ross-Smith M; Monagle P
    Thromb Res; 2007; 120(3):347-51. PubMed ID: 17118432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization of heparin oligosaccharides onto radiofrequency plasma modified pyrolytic carbon-coated graphite.
    Yuan S; Cai W; Szakalas-Gratzl G; Kottke-Marchant K; Tweden K; Marchant RE
    J Appl Biomater; 1995; 6(4):259-66. PubMed ID: 8589511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulant Ability and Heparinization of Decellularized Biomaterial Scaffolds].
    Bao J; Sun J; Zhou Y; Wu Q; Wang Yujia ; Li L; Jiang X; Ma L; Xie Mingjun ; Shi Y; Bu H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):594-8. PubMed ID: 26485984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assays and reference materials for current and future applications of heparins.
    Mulloy B; Hogwood J; Gray E
    Biologicals; 2010 Jul; 38(4):459-66. PubMed ID: 20338781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-functional composite with anticoagulant and antibacterial properties based on heparinized silk fibroin and chitosan.
    Wang J; Hu W; Liu Q; Zhang S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):241-7. PubMed ID: 21459560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
    Wielgos T; Havel K; Ivanova N; Weinberger R
    J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin.
    Zhou Z; Meyerhoff ME
    Biomaterials; 2005 Nov; 26(33):6506-17. PubMed ID: 15941584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro haemocompatibility and stability of two types of heparin-immobilized silicon surfaces.
    Wang A; Cao T; Tang H; Liang X; Salley SO; Ng KY
    Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):245-55. PubMed ID: 15978786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard and method independent units for heparin anticoagulant activities.
    Hemker HC; Béguin S
    Thromb Haemost; 1993 Nov; 70(5):724-8. PubMed ID: 8128425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor.
    Foxall C; Holme KR; Liang W; Wei Z
    Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-functionalized chitosan scaffolds for bone tissue engineering.
    Gümüşderelioğlu M; Aday S
    Carbohydr Res; 2011 Apr; 346(5):606-13. PubMed ID: 21333274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility.
    Li G; Zhang F; Liao Y; Yang P; Huang N
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):255-62. PubMed ID: 20692134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytocompatibility and blood compatibility of multifunctional fibroin/collagen/heparin scaffolds.
    Lu Q; Zhang S; Hu K; Feng Q; Cao C; Cui F
    Biomaterials; 2007 May; 28(14):2306-13. PubMed ID: 17292467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of porous glycosaminoglycan-based scaffolds for expansion of human cord blood stem cells in perfusion culture.
    Cho CH; Eliason JF; Matthew HW
    J Biomed Mater Res A; 2008 Jul; 86(1):98-107. PubMed ID: 17941019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A centrifugation cell adhesion assay for high-throughput screening of biomaterial surfaces.
    Reyes CD; García AJ
    J Biomed Mater Res A; 2003 Oct; 67(1):328-33. PubMed ID: 14517892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M; Luppi E; Maccari F; Volpi N
    Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.